Our commitment: RESULTS

Clinical benefits of the treatment

 

The expected clinical benefits of using MAGNOS STIMULATOR AVN3000-F are:

  • Stimulate bone regeneration and healing. Increases the synthesis of bone collagen and proteoglycans, incorporating a layer of calcium on the affected bone.
  • Accelerates the formation of bone callus. Promotes the proliferative activity of fibroblasts and lymphocytes.
  • Decreases bone resorption. Multiplies vascular penetration.
  • Accelerates endochondral ossification, that is, the calcification of fibrocartilage, accelerating the formation of bone callus.
  • Strengthens bone tissue.
  • Analgesic and anti-inflammatory effect.
  • Accelerates functional recovery and physical function.
  • Improves the quality of life for patients with bone injuries.

Main indications

SM140 MODE

Pathologies associated with fractures:
-Bone edema
-Fractures
-Delayed consolidation
-Fractures with bone loss requiring grafting (with non-magnetic components)
-Complicated fractures from the outset.
-Infected fractures
-Congenital pseudarthrosis (pseudarthrosis, acquired, with or without graft (with non-magnetic components).
-Arthrodesis
-Slow-healing arthrodesis
-Failed or re-operated arthrodesis
-Severely decalcified arthrodesis, to be recalcified
-Osteonecrosis / Osteochondritis
-Tibial plateau
-Carpal and tarsal scaphoid
-Talus
-Reflex sympathetic dystrophy (RSD)
-From the upper limb (shoulder-hand syndrome)
-From the lower limb
-Foot (Sudeck's syndrome)
-Knee
-Hip
-Other clinical forms of RSD
-Parcellaires (highly localized)
-Multifocal
-Regional osteoporosis

AVN750 MODE

-Osteporosis of the femoral head.
-Osteonecrosis / Osteochondritis
-Condyle and femoral head (FICAT stages I, II and III)
-Humeral and metatarsal heads.
-Pelvis fracture.
-Spine vertebrae fractures.

 

 

 

 

 

 

Certified according to Regulation of the European Parliament 745/2017

We want to help you; your recovery is our commitment.